Shengkan Jin active positions
| Companies | Position | Start | End |
|---|---|---|---|
Mito BioPharm LLC
 Mito BioPharm LLC Pharmaceuticals: MajorHealth Technology Mito BioPharm LLC is an American pharmaceutical company that focuses on developing therapies for non-alcoholic fatty liver disease (NAFLD), specifically non-alcoholic steatohepatitis (NASH) and type 2 diabetes. NAFLD is a range of conditions that start with fat accumulation in the liver and can progress to inflammation, fibrosis, cirrhosis, and even liver cancer. Mito BioPharm's drug discovery pipeline and intellectual property are aimed at addressing these conditions. | Director/Board Member | 01/01/2012 | - |
| Chief Tech/Sci/R&D Officer | 01/01/2012 | - | |
| Founder | 01/01/2012 | - |
Career history of Shengkan Jin
Statistics
International
| United States | 2 |
Operational
| Director/Board Member | 1 |
| Chief Tech/Sci/R&D Officer | 1 |
| Founder | 1 |
Sectoral
| Health Technology | 2 |
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
| Private companies | 1 |
|---|---|
Mito BioPharm LLC
Mito BioPharm LLC Pharmaceuticals: MajorHealth Technology Mito BioPharm LLC is an American pharmaceutical company that focuses on developing therapies for non-alcoholic fatty liver disease (NAFLD), specifically non-alcoholic steatohepatitis (NASH) and type 2 diabetes. NAFLD is a range of conditions that start with fat accumulation in the liver and can progress to inflammation, fibrosis, cirrhosis, and even liver cancer. Mito BioPharm's drug discovery pipeline and intellectual property are aimed at addressing these conditions. | Health Technology |
- Stock Market
- Insiders
- Shengkan Jin
- Experience
